Advertisement
Screener

Protalix BioTherapeutics, Inc. (PLX) Pre-Tax Margin

Protalix BioTherapeutics, Inc. (PLX) Pre-Tax Margin

  • 2026-06-30: Pre-Tax Margin 24.43%.
  • 2026-03-31: Pre-Tax Margin 62.64%.
  • 2025-12-31: Pre-Tax Margin -52.36%.
  • 2025-09-30: Pre-Tax Margin 12.54%.

Complete source-backed pre-tax margin history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical Pre-Tax Margin

DatePre-Tax Margin
2026-06-3024.43%
2026-03-3162.64%
2025-12-31-52.36%
2025-09-3012.54%
2025-06-304.22%
2025-03-31-36.90%
2024-12-3140.16%
2024-09-3021.40%
2024-06-30-16.86%
2024-03-31-126.28%
2023-12-31-61.28%
2023-09-30-16.62%
2023-06-3056.01%
2023-03-31-30.62%
2022-12-31-37.25%
2022-09-30-25.15%
2022-06-30-60.94%
2022-03-31-14.21%

Annual Pre-Tax Margin

DatePre-Tax Margin
2025-12-31-10.63%
2024-12-317.78%
2023-12-3113.08%
2022-12-31-30.22%
2021-12-31-71.92%
2020-12-31-10.37%

Similar stocks

Stock NameCountryMarket CapPE Ratio
ANAVEX LIFE SCIENCES CORP. (AVXL)United States$0.218B-18.37
Alector, Inc. (ALEC)United States$0.213B-1.90
Compass Therapeutics, Inc. (CMPX)United States$0.204B-5.35
Aligos Therapeutics, Inc. (ALGS)United States$0.238B-0.47
Lineage Cell Therapeutics, Inc. (LCTX)United States$0.241B-10.35
Protara Therapeutics, Inc. (TARA)United States$0.198B-3.22
Alpha Cognition Inc. (ACOG)$0.185B-6.77
Coherus Oncology, Inc. (CHRS)United States$0.182B-1.63
SUTRO BIOPHARMA, INC. (STRO)United States$0.260B-3.05
PRECISION BIOSCIENCES INC (DTIL)United States$0.175B-3.95